Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFAM | ISIN: KYG3932F1063 | Ticker-Symbol:
NASDAQ
14.01.25
22:00 Uhr
0,918 US-Dollar
0,000
0,00 %
Branche
Elektrotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
SUNRISE NEW ENERGY CO LTD Chart 1 Jahr
5-Tage-Chart
SUNRISE NEW ENERGY CO LTD 5-Tage-Chart
GlobeNewswire (Europe)
139 Leser
Artikel bewerten:
(0)

Sunrise New Energy Co., Ltd: Sunrise Sunrise Reports Strong Sales Growth Driven by Leading EV and Energy Storage Customers

Finanznachrichten News

ZIBO, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. ("Sunrise", the "Company", "we" or "our") (NASDAQ: EPOW), today announced robust sales growth, highlighting its expanding influence in the electric vehicle (EV) and energy storage sectors. In October 2024, the Company achieved a sales volume of 3,419 tons, representing an extraordinary 449.8% increase compared to October 2023. From January to October 2024, cumulative sales reached 22,476 tons, marking a 131.1% increase compared to the same period in 2023.

This surge in orders was driven by partnerships with industry-leading battery manufacturers, including:

  • Contemporary Amperex Technology Co., Limited (CATL), the world's largest EV and energy storage battery manufacturer, holding approximately 40% of the global market share (source: https://en.wikipedia.org/wiki/CATL).
  • HiTHIUM Energy Storage, a prominent producer of premium stationary energy storage batteries (source: https://hithium.com/en/).
  • Pylon Technologies Co., Ltd., a pioneer in energy storage, known as "China's First Energy Storage Stock". (source: https://en.pylontech.com.cn/about/company).

"We are extremely proud of this significant order growth and expect even stronger sales in the final two months of 2024. It's a testament to the superior quality of our products and our position at the forefront of the anode material industry." stated Mr. Haiping Hu, CEO of Sunrise. " Earning the trust of world-class customers like CATL, HiTHIUM, and Pylon Technologies demonstrates the strength of our technologies and our uncompromising commitment to product quality. We remain dedicated to delivering exceptional financial performance and creating long-term value for our shareholders."

About Sunrise New Energy Co., Ltd

Headquartered in Zibo, Shandong Province, China, Sunrise New Energy Co., Ltd., through its joint venture, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. The Company's joint venture has completed the construction of a manufacturing facility with a production capacity of 50,000 tons in Guizhou Province, China. The plant runs on inexpensive electricity from renewable sources, which helps to make Sunrise New Energy a low-cost and low-environmental-impact producer of graphite anode material. Mr. Haiping Hu, the founder and CEO of the Company, is a major pioneer for the graphite anode industry in China starting from 1999. The Company's management team is also composed of experts with years of experiences and strong track-records of success in the graphite anode industry. In addition, the Company also operates a knowledge sharing platform in China. For further information, please visit the Company's website at www.sunrisenewenergy.com.

Forward-looking statement

Certain statements in this press release regarding the Company's future expectations, plans and prospects constitute forward-looking statements as defined by Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about plans, goals, objectives, strategies, future events, expected results, assumptions and any other factual statements that have not occurred. Any words that refer to "may", "will", "want", "should", "believe", "expect", "expect", "estimate", "estimate" or similar non-factual words, shall be regarded as forward-looking statements. Due to various factors, the actual results may differ materially from the historical results or the contents expressed in these forward-looking statements. These factors include, but are not limited to, the company's strategic objectives, the company's future plans, market demand and user acceptance of the company's products or services, technological updates, economic trends, the company's reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, the ups and downs of China's macroeconomic conditions, the relevant international market conditions, and other related risks and assumptions disclosed in the Company's Annual Report on Form 20-F published on the SEC's website. In view of the above and other related reasons, we urge investors to visit the SEC's website and consider other factors that may affect the Company's future operating results. The Company is under no obligation to make public amendments to changes in these forward-looking statements unless required by law.

For more information, please contact:

The Company:

IR Department

Email: IR@sunrisenewenergy.com

Phone: +86 4009919228


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.